Finance

Lists
KMTS:NASDAQ
Kestra Medical Technologies Ltd
$23.15
+1.76%
(+0.40) 1D
$23.15
0.00% (0.00)
After hours
Closed: Jul 30, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KMTS...
Open
$22.91
High
$24.00
Low
$22.22
Mkt. cap
1.36B
Avg. vol.
440.80K
Volume
283.75K
52-wk high
$30.00
52-wk low
$14.10
EPS
-$2.43
Shares outstanding
58.60M
No. of employees
443
Open
$22.91
High
$24.00
Low
$22.22
Mkt. cap
1.36B
Avg. vol.
440.80K
Volume
283.75K
52-wk high
$30.00
52-wk low
$14.10
EPS
-$2.43
Shares outstanding
58.60M
No. of employees
443
News stories
From sources across the web
About Kestra Medical Technologies Ltd
CEO-
Employees443
Founded2014
HeadquartersKirkland, Washington, United States
SectorMedical device
Websitekestramedical.com
Analyst ratings
Based on 6 analysts giving stock ratings to KMTS in the past 3 months
Strong buy
Buy
5
Hold
1
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for KMTS in the last 3 months.
Highest
Current $23.15
$32.00 (+38.23%)
Average
$30.00 (+29.59%)
Lowest
$28.00 (+20.95%)
Analyst
Recommendation
Action
Price target
Projected
Date
Suraj Kalia
Oppenheimer
Hold
Initiated
-
-
07/21/2026
Matthew O'Brien
Piper Sandler
Buy
Maintained
$30.00
+29.6%
07/15/2026
Rick Wise
Stifel Nicolaus
Buy
Maintained
$30.00
+29.6%
07/15/2026
Travis Steed
Bank of America Securities
Buy
Reiterated
$30.00
+29.6%
07/16/2026
Marie Thibault
BTIG
Buy
Reiterated
$32.00
+38.2%
07/15/2026
Larry Biegelsen
Wells Fargo
Buy
Reiterated
$28.00
+21%
07/15/2026
David Roman
Goldman Sachs
Hold
Reiterated
$17.00
-26.6%
04/09/2026
Unknown Analyst
Wells Fargo
Buy
Reiterated
$28.00
+21%
03/18/2026
Last report
Jul 14, 2026
Fiscal period
Q4 2026
EPS / Est. (USD)
-$0.49 / -$0.58
+15.76%beat
Revenue / Est. (USD)
28.64M / 26.48M
+8.15%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
-
-
-
-
Total operating expenses
-
-
-
-
Operating income
-
-
-
-
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-
-
EBT excluding unusual items
-
-
-
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-
Net profit margin
-133.32%
-145.29%
-139.16%
-135.61%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps